We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Harvard Pilgrim, Amgen Reach Pay for Performance Agreement
Harvard Pilgrim, Amgen Reach Pay for Performance Agreement
Amgen has struck a deal with Harvard Pilgrim Health Care, through which it could pay rebates if its new cholesterol drug Repatha does not perform as well as it did in clinical trials.